LUGPA 2025 Global Prostate Cancer Congress Enduring Program-GPCC 2025 Session 10

Video Transcription

Video Summary

The transcript features discussions from a prostate cancer conference focusing on exercise, treatment side effects, advanced therapies, and innovations in patient care. Arturo Mendoza Valdez highlights exercise as beneficial in reducing prostate cancer risk, mitigating side effects of treatments like androgen deprivation therapy (ADT), surgery, and radiotherapy, citing studies showing improved physical fitness, reduced fatigue, anxiety, and depression. The importance of over 150 minutes of weekly exercise is emphasized.<br /><br />Dr. Klotz offers insights into managing ADT side effects, stressing statins' role beyond cholesterol, inhibiting androgen synthesis pathways to delay resistance, and advocating for bone loss prevention with bisphosphonates like alendronate. He discusses metformin's potential in countering ADT's metabolic effects and supplements this with data on exercise improving tumor microenvironment and outcomes. He addresses controversies around intermittent ADT versus continuous therapy, suggesting individualized approaches.<br /><br />Dr. Patel reviews functional outcomes post-radical prostatectomy, focusing on erectile dysfunction (ED) and urinary incontinence. He outlines causes of nerve damage and current rehabilitation strategies including daily PDE5 inhibitors, pelvic floor therapy, vacuum devices, and emerging treatments like perinatal tissue allografts and low-intensity shockwave therapy. Incontinence management encompasses conservative measures progressing to surgical interventions and use of innovative penile compression devices.<br /><br />Clinical cases illustrate diagnostic challenges, particularly with PSMA PET scans and biopsy confirmation to avoid overtreatment. Late-breaking abstracts feature AI-enabled platforms improving clinical trial patient matching, and large genomic registries aiding personalized prostate cancer management. The novel iso-PSA assay shows promise in early detection, especially in biopsy-naïve patients.<br /><br />Overall, the conference conveys the multifaceted approach to prostate cancer—combining exercise, pharmacologic adjuncts, cutting-edge diagnostics, and rehabilitation to improve survivorship and quality of life.

Keywords

prostate cancer

exercise benefits

androgen deprivation therapy

ADT side effects

statins in prostate cancer

bone loss prevention

bisphosphonates

metformin metabolic effects

radical prostatectomy outcomes

erectile dysfunction rehabilitation

urinary incontinence management

AI in clinical trials